1. Market Research
  2. > Healthcare Market Trends
United States Healthcare BPO Market - Growth, Trends, and Forecast (2019 - 2024)

United States Healthcare BPO Market - Growth, Trends, and Forecast (2019 - 2024)

  • May 2019
  • 91 pages
  • ID: 5778475
  • Format: PDF
  • By Mordor Intelligence LLP

Summary

Table of Contents

Search Inside

Market Overview
The United States Healthcare BPO Market was valued at USD 109.84 billion in 2018, and it is expected to reach USD 174.59 million by 2024, with an anticipated CAGR of 8.11% during the forecast period, 2019-2024.

According to the US federal government reports, around USD 3.65 trillion was spent on healthcare in 2018, which means that the spending was around USD 11,212 per person, with 59% of the spending was on hospitals, clinical services, and doctors. The National healthcare expenditure (NHE) grew by 4.4% when compared to 2017. As per National Health Expenditure Projections 2018-2027, the projected growth of the national health spending is around the average rate of 5.5% per year for 2018-27, which is anticipated to reach nearly USD 6.0 trillion by 2027. The health share of GDP is expected to increase from 17.9% in 2017 to 19.4% by 2027. The healthcare spending by the payer is expected to rise with faster growth rates, for example, Medicare spending growth was projected to have an accelerated growth to 5.9% in 2018, from 4.2%, and Medicaid spending was witnessing growth more slowly in 2018, at 2.2% from 2.9% in 2017. A similar trend has been observed in National Health Expenditures by Sector, prescription drug spending is projected to have grown 3.3%, hospital spending is projected to have grown 4.4%, and physician and clinical services spending is projected to have grown more rapidly at 4.9%, in 2018. With increasing healthcare costs, people seem to be skipping physician visits, skipping medical care or delaying care ultimately impacts the quality of care and lead to an increased cost of care. The main function of healthcare is diagnosing and treating patients, which are achieved by healthcare organizations by focusing on is increasing staff efficiency and delivering proper patient care. There is a need to balance the number of non-care responsibilities a staff member can handle in a healthcare organization, in order to improve quality patient care and in turn, the overall cost of the revisits and re-treatment can be controlled. This can be achieved by proper implementation of the outsourcing for non-core activities, the Healthcare BPO can lower the costs through outsourcing the professionals on behalf of the healthcare company. The money can be saved on both acquiring additional staff and training them. Similarly, outsourcing can provide access to specialists, which enhances the availability of skilled healthcare professionals. Their expertise and experience can complete a complex task in a short period of time and save a lot of labor costs. With increasing regulatory compliance and rise in healthcare costs, healthcare BPO will witness exponential growth, due to more healthcare facilities and hospitals outsourcing non-core activities for better operational benefits, such as improved patient care, predictable cash flow, and increased net revenue.

Scope of the Report
The healthcare BPO (business process outsourcing) refers to a process, in which the healthcare providers select the most suited third-party vendor for specific business processes. It allows the hospitals and medical professionals to spend their energy and valuable time on patient care.

Key Market Trends
Claims Management is Expected to Grow with High CAGR in the Forecasted Period

The United States healthcare system is a trillion-dollar industry, which includes pharmacies, pharmaceutical companies, medical equipment manufacturers, and medical care facilities. This complex infrastructure in this industry relies on a specialized professional who is overseeing these operations. One such process is a medical claim. The claim process is summarized as a dual interaction between two of the largest and the important parts of the healthcare system, namely healthcare providers and medical insurance companies. The relationship between policyholders, healthcare providers, and insurance companies is essential for understanding the details of medical billing and coding process. Medical claims management is the organization, billing, filling and updating, and processing of the medical claims, related to the patient diagnosis, treatments, and medications. Many hospitals and medical facilities outsource these tasks to medical claims management firms as maintaining patient records, interacting with health insurance agencies, and issuing invoices for medical services is a time consuming process. Medical claims management services process electronic and hard-copy data to determine what the patients owe and what costs insurance companies cover. These services process billing and send invoices to patients and insurance agencies to ensure patients have paid their respective portions of the expenses. In some cases, Medicare, Medicaid, and state sponsored agencies also pay some of the medical expenses. Claims management market will augment in the forecast period, as they are essential part of the healthcare industry in the United States.

Competitive Landscape
The United States Healthcare BPO market is competitive and consists of a major players and minor players. In terms of market share, these major players currently dominate the market. Some of the major players of the market are Accenture plc, Genpact Limited, IBM Corporation, Parexel International, and Cognizant are among others.

Reasons to Purchase this report:
- The market estimate (ME) sheet in Excel format
- Report customization as per the client’s requirements
- 3 months of analyst support

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
10% Off

($3250)

  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Anthrax - Pipeline Review, H2 2019

Anthrax - Pipeline Review, H2 2019

  • $ 2000
  • November 2019

Anthrax - Pipeline Review, H2 2019SummaryThis latest Pharmaceutical and Healthcare disease pipeline guide Anthrax - Pipeline Review, H2 2019, provides an overview of the Anthrax (Infectious Disease) pipeline ...

Optic Neuropathy - Pipeline Review, H2 2019

Optic Neuropathy - Pipeline Review, H2 2019

  • $ 2000
  • November 2019

Optic Neuropathy - Pipeline Review, H2 2019SummaryThe latest Pharmaceutical and Healthcare disease pipeline guide Optic Neuropathy - Pipeline Review, H2 2019, provides an overview of the Optic Neuropathy ...

Global Oral Anti-Diabetic Drugs Market: World Market - Opportunities and Forecast (2019-2024)

Global Oral Anti-Diabetic Drugs Market: World Market - Opportunities and Forecast (2019-2024)

  • $ 2400
  • October 2019

Executive SummaryThe Oral anti diabetes drug was valued at USD 25.6 Billion in the year 2018. Over the recent years, oral anti-diabetes drug has been witnessing considerable growth on the back of rising ...


ref:plp2019

Reportlinker.com © Copyright 2019. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on